SCHEMBL27869032

SCHEMBL27869032

COc1c(F)cnc2[nH]ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 3/20 0.46
▸ AXL P30530 1/20 0.45
▸ PRKCI P41743 1/20 0.45
▸ RPS6KA3 P51812 3/20 0.45
▸ NUDT1 P36639 1/20 0.44
▸ TRPA1 O75762 4/20 0.41
▸ TTBK1 Q5TCY1 1/20 0.40
▸ TTBK2 Q6IQ55 1/20 0.40
▸ NTRK1 P04629 2/20 0.39
▸ FGFR1 P11362 2/20 0.39
▸ KDR P35968 2/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ KIT P10721 1/20 0.39
▸ FGFR2 P21802 1/20 0.39
▸ FGFR3 P22607 1/20 0.39
▸ MAP3K11 Q16584 2/20 0.39
▸ AURKA O14965 1/20 0.39
▸ DAPK3 O43293 1/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ PRKD3 O94806 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16588527 0.81 PRKCI (0.59) BRD4AXLPRKCIRPS6KA3NUDT1
SCHEMBL12563103 0.81 PRKCI (0.54) BRD4AXLPRKCIRPS6KA3TTBK1
SCHEMBL27939133 0.80 AXL (0.40) AXLPRKCIRPS6KA3NUDT1TRPA1
SCHEMBL1566092 0.79 PRKCI (0.49) BRD4AXLPRKCIRPS6KA3TTBK1
SCHEMBL21677833 0.79 BRD4 (0.43) BRD4AXLPRKCIRPS6KA3TTBK1
SCHEMBL16548436 0.77 PRKCI (0.53) AXLPRKCIRPS6KA3NUDT1TRPA1
SCHEMBL15154891 0.76 KDR (0.47) BRD4AXLPRKCINUDT1TRPA1
SCHEMBL29660498 0.76 NUDT1 (0.50) AXLPRKCIRPS6KA3NUDT1TRPA1
SCHEMBL1467759 0.76 NUDT1 (0.50) AXLPRKCIRPS6KA3NUDT1TRPA1
SCHEMBL16588526 0.74 BRD4 (0.42) BRD4AXLPRKCINUDT1TTBK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102459267-A Dihydropyrrolonaphtyridinone compounds as inhibitors of jak TAKEDA PHARMACEUTICAL 2012-05-16 — — CN disclosed
Send feedback